Danilon

Quick links to important sections

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Danilon

Quick Facts

Property Description
Active ingredient Norfloxacin
Form Oral tablet
Pharmacological class Fluoroquinolone antibiotic
Common use Systemic treatment of bacterial infections
Origin Synthetic

Defining Danilon: Class and Origin of the Antibacterial Agent

Danilon is a trade name for a medicine whose active component is the synthetic compound Norfloxacin, which functions as a potent broad-spectrum antibacterial agent. This compound is systematically classified as a fluoroquinolone antibiotic, placing it within the larger quinolone group of anti-infective medications. Norfloxacin is entirely manufactured via chemical processes, confirming its origin as synthetic. The structural modification that defines the fluoroquinolone group enhances the drug's activity against various bacteria, a characteristic well-recognized in clinical pharmacology.

Composition and Physical Form of Danilon

The principal substance in the Danilon formulation is the active ingredient Norfloxacin, making it a single active ingredient product. Danilon is typically presented as a solid preparation, formulated as an oral tablet for systemic administration. The tablet base, made of pharmaceutical excipients, ensures the stable and proper release of the Norfloxacin into the bloodstream. This oral route allows the drug to be absorbed through the digestive system and distributed throughout the body to address bacterial infections systemically, a method approved for this agent.

General Purpose: How the Bactericidal Action Benefits Treatment

The general purpose of Danilon is to eliminate infections by directly killing susceptible microorganisms, functioning as a powerful bactericidal agent. The drug achieves its goal by inhibiting two essential bacterial enzymes, DNA gyrase and DNA topoisomerase IV. This targeted action disrupts the cell's genetic processes, leading to the rapid and direct destruction of the pathogen. This core bactericidal mechanism, characteristic of Norfloxacin, underpins the drug's utility in effectively counteracting the presence of active bacterial infections. For example, it is clinically recognized for its effectiveness against common bacteria that cause uncomplicated urinary tract infections.

What side effects are possible with Danilon?

Possible side effects and safety information

The general principles governing the safety profile of Danilon, whose active ingredient is the fluoroquinolone antibiotic Norfloxacin, are strictly documented by regulatory authorities, classifying effects by frequency and the body system affected. The safety profile is characterized by the potential for certain serious adverse reactions which may be disabling or potentially irreversible.

Officially Classified Adverse Reactions and Frequency

Classification Representative Adverse Reactions
Common (ge 1% to <10%) Nausea, headache, dizziness, elevated liver enzymes (ALT/AST).
Uncommon (ge 0.1% to <1%) Insomnia, anxiety, depression, blurred vision, crystalluria.

Adverse reactions are grouped by System-Organ Class, with effects noted in the Gastrointestinal, Nervous System, Musculoskeletal, Psychiatric, and Dermatological domains.

Serious Adverse Reactions and Safety Constraints

Norfloxacin is officially associated with serious adverse reactions, which may involve multiple body systems. The most clinically significant risks documented in regulatory materials include Tendon Rupture (often the Achilles tendon) and debilitating Peripheral Neuropathy, which can involve pain, burning, tingling, or weakness in the extremities. Both of these effects may occur during treatment or up to several months after stopping the medication. Other serious effects include Seizures and Toxic Psychosis, as well as the risk of serious cardiac events like QTc interval prolongation and Ventricular Arrhythmia.

Specific safety considerations are outlined for certain patients: use is contraindicated in patients with Myasthenia Gravis due to the risk of exacerbating muscle weakness. Older patients are noted to be at an increased risk of tendon disorders and aortic events (aneurysm and dissection). Furthermore, adequate hydration must be maintained to minimize the risk of crystalluria, and excessive sun exposure should be avoided due to the potential for severe photosensitivity reactions.

Overdose and Emergency Response

Overdose and when to seek help

Acute overexposure to Danilon (Norfloxacin) may result in various documented systemic manifestations. The common reported overdose presentations involve gastrointestinal distress, including nausea, vomiting, and diarrhea. Severe effects primarily involve the Central Nervous System (CNS), with documented symptoms such as dizziness, confusion, tremor, hallucinations, and potentially more serious events like convulsions or seizures.


Regulatory Focus Documented Overdose Risk
Severe Outcomes Risk of acute renal failure due to crystalluria and potential cardiotoxicity from QT interval prolongation.
Special Populations Patients with pre-existing renal impairment and the elderly population may face increased risk or severity.

Mandatory Emergency Actions

Regulatory documents state explicitly that immediate medical attention must be sought if an overdose is suspected or upon recognition of any overdose symptoms. Management is symptomatic and supportive, as no specific antidote is known for Norfloxacin overdose. Hospital monitoring is required, specifically including ECG monitoring for cardiac function and continuous monitoring of renal function due to the crystalluria risk. Procedures such as gastric lavage or the administration of activated charcoal may be considered to reduce systemic absorption if performed shortly after ingestion.

Therapeutic Uses of Danilon

Danilon is commonly used to help with symptomatic relief and supportive assistance, applied across domains where additional symptomatic support is needed. The therapeutic benefit is relevant for symptoms related to inflammatory or irritative states. The compound class is relevant for easing symptoms related to increased neurological or muscular activity.

Management of Acute Symptomatic Episodes

This medication is applied across domains where short-term symptom management is appropriate, particularly in situations involving certain distressing symptoms that may intensify temporarily. It is used when symptoms create noticeable physiological strain. It helps address symptom clusters that may become intense or disruptive.

“It assists with managing symptoms, which contributes to easing the overall symptom load and supports general well-being during symptomatic phases.”

Easing Pronounced and Disruptive Manifestations

Danilon is relevant in contexts marked by increased discomfort or tension, and across conditions presenting with acute episodes. It is applied when symptoms create noticeable functional strain. It is considered relevant in situations where multiple symptoms occur together, and may assist with managing symptoms that interfere with daily comfort. It assists with managing symptoms, which contributes to improved day-to-day comfort during symptomatic periods.

Quick Fact: Relief for Acute Discomfort The medication is considered relevant for easing symptoms associated with acute or episodic changes, particularly when symptoms of physical discomfort become disruptive during flare-ups.

Regulatory References

  1. NIH DailyMed records for Phenylbutazone

Eligibility and Restrictions for Use

Danilon (Norfloxacin) is generally approved for use in adult patients aged 18 years and older who meet specific eligibility criteria. Regulatory authorities define strict exclusions based on medical history, age, and physiological status.


Contraindicated Populations

Use is absolutely contraindicated if a patient has a history of hypersensitivity or severe allergic reaction to Norfloxacin or any related fluoroquinolone antibiotic. The medicine must not be used by patients with a history of tendinitis or tendon rupture linked to previous fluoroquinolone exposure, or by individuals diagnosed with Myasthenia Gravis.

Furthermore, Danilon is generally contraindicated during pregnancy and lactation. Its use is not established and not recommended for children or growing adolescents (under 18 years of age) due to potential musculoskeletal risks.


Restricted and Conditional Use

Use requires caution in specific adult populations and may necessitate conditional eligibility. This includes patients over 60 years of age, those taking systemic corticosteroids, or individuals with a history of organ transplantation, all of whom are identified as having an increased risk of tendon complications.

Use also requires caution in patients with severe renal impairment, often requiring a dosage adjustment due to the drug’s elimination pathway. Caution is also advised for patients with a history of seizures or conditions that may prolong the heart's QT interval.

What should I know about interactions with other medicines?

Danilon (Norfloxacin) has officially documented interaction patterns that are classified based on their effect on drug absorption, systemic exposure, and pharmacodynamic outcomes.

Absorption and Timing Separation

Co-administration with substances containing polyvalent cations results in significantly reduced absorption of Norfloxacin. This includes certain antacids, sucralfate, and supplements containing iron or zinc. To mitigate this pharmacokinetic interaction, official labeling mandates that these products must be separated from Danilon administration by at least a two-hour period. Ingesting milk, yogurt, or calcium-fortified foods may also decrease absorption and requires a similar timing separation.


Exposure Alteration and Contraindication

Norfloxacin is documented to inhibit the CYP1A2 enzyme pathway, which can lead to elevated plasma concentrations of co-administered agents metabolized by this pathway, such as Theophylline and Caffeine. The combination with Tizanidine is formally contraindicated due to the high risk of severely increased Tizanidine exposure. Furthermore, co-administration with Cyclosporine may result in elevated serum levels of that drug, a scenario that requires close monitoring.


Additive and Pharmacodynamic Effects

There are official cautions regarding pharmacodynamic interactions, including the use with oral anticoagulants (like Warfarin), as this combination may enhance anticoagulant effects and necessitates frequent monitoring of INR. The combination with NSAIDs carries a documented increased risk of CNS stimulation. The label also notes that when co-administered with systemic corticosteroids, particularly in patients over 60 years of age, there is an established major risk factor for tendon rupture.

Mechanism of Action

The active mechanism of Danilon (Norfloxacin) is centered on the disruption of core genetic processes essential for the viability and proliferation of susceptible bacteria. This action is characterized as bactericidal.

Blocking Bacterial DNA Management Enzymes

The drug functions by specifically targeting and inhibiting two bacterial enzymes essential for genetic integrity: DNA Gyrase and DNA Topoisomerase IV. Norfloxacin binds to and stabilizes the cleavable complex where these enzymes temporarily cut the bacterial DNA strands. This interaction arrests the enzymes, preventing them from completing the crucial re-ligation step and thereby blocking their ability to manage the necessary coiling and separation of the bacterial chromosome.

Initiating Lethal DNA Damage and Cell Collapse

The accumulating, irreversible breaks and structural stresses imposed on the bacterial DNA by the inhibited enzymes trigger a profound cascade of damage. This leads to the activation of the bacterial SOS response, which, when overwhelmed, initiates the cell's self-destruction pathways. The resulting physiological effect is the rapid, direct disintegration (lysis) of the bacterial cell. This action defines the functional classification of the mechanism. The mechanism is constrained by bacterial adaptations like efflux pumps or enzyme mutations that reduce the drug's access to or affinity for its targets.

Dosage and Administration Information

Administration of Danilon (Norfloxacin)

The medicine Danilon, which contains Norfloxacin, is approved for oral administration as a tablet for systemic therapy. The standard pattern of use is 400 mg taken twice daily, meaning the two doses should be scheduled approximately 12 hours apart. For specific acute infections, a single 800 mg administration is utilized; this figure also represents the maximum total daily dosage established by regulatory agencies.


Timing and Dietary Context

A principal instruction for proper use involves the timing of the tablet relative to food intake. To maximize absorption, the tablet must be taken with water at least one hour before or two hours after consuming any meal, milk, or other dairy products. Additionally, co-administration with certain over-the-counter products, such as supplements containing iron or zinc, as well as antacids or sucralfate, is restricted. The intake of Danilon must be separated from these items by at least two hours.


Course Duration and Dose Adjustments

The duration of the treatment course is highly variable, ranging from a short, three-day regimen for certain uncomplicated infections to an extended course of up to twenty-eight days for complex conditions like prostatitis. Usage instructions mandate a dose reduction for individuals with impaired kidney function. Patients whose creatinine clearance (CrCl) is 30 mL/min or less are instructed to reduce the dose to 400 mg once daily. Official regulatory documentation does not provide established instructions for use in the pediatric population.

Recent Clinical Evidence

Research Evidence / Overview of Studies for Danilon

This section provides an overview of the types of research and clinical trials that have evaluated Norfloxacin, the active ingredient in Danilon, focusing on what was studied and where limitations in the evidence exist. Research findings describe group patterns and do not determine whether an individual will respond similarly.


Evidence for Uncomplicated Urinary Tract Infections (UTI)

Norfloxacin was studied for use in uncomplicated urinary tract infections (UTI), such as cystitis, primarily through short-term Randomized Controlled Trials (RCTs) and older regulatory clinical evaluation studies. Research examined the clinical cure rate and the microbiological eradication rate. The clinical relevance of the findings is continually assessed as scientific reports indicate the increasing prevalence of bacterial resistance to the fluoroquinolone class. This impacts the interpretation of historical findings, suggesting data for certain bacteria remain insufficient in today's context.


Evidence for Research Exploring the Reduction of Spontaneous Bacterial Peritonitis (SBP) Incidence

The active ingredient was studied in research exploring the reduction of Spontaneous Bacterial Peritonitis (SBP) incidence in high-risk adult patients with liver cirrhosis and ascites. Research used Systematic Reviews, Meta-analyses, and RCTs to examine outcomes like the incidence of SBP recurrence and patterns related to overall survival. The certainty remains low regarding the agent's long-term performance compared against newer prophylactic treatments, and evidence suggests documented decreases in the described efficacy were observed in some studies over time, often associated with the emergence of multidrug-resistant organisms (MDROs).


What Remains Unclear and Evidence Gaps

Evidence highlights that research is ongoing to better understand the appropriate role of Norfloxacin given the global rise in antibiotic resistance. The weight of evidence varies across studies, and comparative evidence against current, first-line treatments is often lacking or historical. A key limitation is that sample sizes were modest in some of the older trials, and information characterizing long-term outcomes remains limited across all indications.

Frequently Asked Questions (FAQ)

Common questions about Danilon (FAQ)

Q: How long does the effect of a Danilon dose usually last?

A: Official information regarding the pharmacokinetics of Danilon (Norfloxacin) describes its half-life as generally falling between 3 and 4 hours. The half-life is the time it takes for the concentration of the medicine in the body to be reduced by half. The drug is typically prescribed to be taken in a manner that maintains appropriate levels.


Q: Can Danilon be taken at the same time as paracetamol (acetaminophen)?

A: Regulatory documents do not specifically list Paracetamol (Acetaminophen) as a known interaction or contraindication for Danilon. The lack of a specific warning in official labeling generally indicates a significant adverse interaction has not been formally documented.


Q: What are the signs of a serious allergic reaction to Danilon?

A: Serious hypersensitivity reactions, including anaphylaxis, have been reported with Danilon use. Symptoms can include swelling of the face, throat, or lips, severe difficulty breathing, a generalized rash, hives, or fever. These symptoms require immediate attention.


Q: Does Danilon interact with common vitamin supplements?

A: Official documents explicitly restrict the co-administration of Danilon with supplements containing iron or zinc. These should be taken at least two hours apart because they can significantly reduce how much Norfloxacin the body absorbs. The interaction status of other specific vitamins is not typically detailed in the official prescribing information.


Q: Can Danilon be used by older adults?

A: Danilon is not generally contraindicated based on age alone. However, official warnings note that older patients, generally those over 60 years of age, have an increased risk of tendon damage (tendinopathy), especially when the drug is taken alongside systemic corticosteroids. This highlights the need for consideration when the drug is used in this age group.


Q: Can Danilon be crushed or split if a person has trouble swallowing?

A: Official instructions and patient information generally indicate that Danilon tablets should be swallowed whole with water. Official instructions indicate the tablet should be swallowed whole, as modifying it can affect how the medicine is absorbed and functions.


Q: Can Danilon cause weight gain?

A: While not listed as a common side effect, regulatory documents have sometimes reported weight changes as an occasional or uncommon adverse experience. It is important to discuss any significant or unexpected changes in weight with a healthcare provider.


Q: Is it common to feel tired or drowsy when taking Danilon?

A: Reported adverse reactions involving the central nervous system (CNS) include feelings of dizziness, somnolence (drowsiness), and asthenia (unusual weakness or tiredness). Official patient warnings advise that activities requiring alertness should be performed with caution if these effects are experienced.


Q: Does Danilon affect sleep patterns?

A: Yes, official documents list changes to sleep patterns among the reported nervous system and psychiatric adverse reactions. Specifically, insomnia (difficulty falling or staying asleep) and dream abnormalities have been reported by patients using this medication.


Q: Can Danilon be taken with coffee or tea?

A: Danilon is documented to interfere with the metabolism of caffeine. This means that consuming products containing caffeine, such as coffee, tea, and some soft drinks, may lead to increased concentrations of caffeine in the bloodstream, potentially causing related effects like nervousness or excitability.


Q: What kind of stomach issues are most often linked to Danilon use?

A: Common gastrointestinal adverse reactions listed in the official documents include nausea, diarrhea, abdominal pain, and symptoms like stomach cramps or heartburn. These are typical side effects reported with many orally administered antibiotics.


Q: What should I know about taking Danilon if I have high blood pressure?

A: Official documents list hypertension (high blood pressure) as a potential occasional cardiovascular adverse experience. Furthermore, some regulatory warnings advise caution regarding pre-existing cardiovascular conditions, including high blood pressure, due to potential risks like aortic aneurysm or dissection.


Q: Are there any specific foods to avoid while using Danilon?

A: Official guidelines state that dairy products, such as milk or yogurt, and calcium-fortified foods must be avoided within the specified time window of administration. This separation is necessary because calcium can significantly decrease the absorption of Danilon.


Q: What is the difference between Danilon and other common anti-inflammatory drugs?

A: The mechanism of Danilon is officially described as bactericidal, meaning its function is to directly kill susceptible bacteria by disrupting their genetic integrity. This makes it an antibiotic for treating infections, which is fundamentally different from anti-inflammatory drugs.


Q: Is it true that Danilon is sometimes used for conditions other than joint pain?

A: Yes, Danilon is officially indicated for various bacterial infections, such as those affecting the urinary tract (UTIs) and the prostate (prostatitis). The drug is an antibiotic and is not officially indicated or used for the treatment of joint pain itself.


Q: Is Danilon safe to use if I have a history of kidney issues?

A: Official product information mandates a dose reduction for patients who have significant impairment of kidney function (a creatinine clearance of 30 mL/min or less). This guidance indicates that kidney function is a critical factor that is considered for use of Danilon.


Q: What happens if I miss a dose of Danilon?

A: Official patient instructions typically advise that if a dose is missed, the next dose should be taken at the regularly scheduled time. Official patient information clarifies that patients should not double the dose to compensate for a missed one.


Q: Can Danilon cause changes in mood or anxiety?

A: Official regulatory documents list several psychiatric adverse reactions that have been reported with Danilon, including anxiety, nervousness, confusion, and depression. These are Central Nervous System (CNS) effects that have been officially reported.


Q: Are there specific restrictions for driving or operating machinery while taking Danilon?

A: Due to the potential for side effects like dizziness or lightheadedness, official warnings advise caution regarding activities that require full alertness. Official patient warnings advise against driving or operating heavy machinery until a person knows how the drug affects their individual concentration and reaction.


Q: Is Danilon available over the counter, or is it prescription only?

A: Danilon (Norfloxacin) is formally classified by major regulatory bodies as a prescription-only medication. This means it can only be dispensed under the direction and supervision of a licensed healthcare professional.


Q: Is there research looking into the long-term effects of Danilon?

A: Official clinical trial information confirms that studies have assessed the long-term effects of Danilon for specific uses. Follow-up periods of 6 to 12 months are described in research investigating prolonged use, such as for the prevention of infection in certain chronic conditions.


Q: How does Danilon affect the liver?

A: Official documents list potential hepatic (liver) adverse reactions, including elevated liver function tests, hepatitis, and jaundice (yellowing of the skin). There have also been reports of fatal cases of hepatic failure associated with its use.


Q: Can people with diabetes use Danilon?

A: Official warnings state that medicines like Danilon can cause blood sugar levels to become unbalanced in patients with diabetes, potentially causing levels to rise or drop significantly. Official warnings advise that blood glucose levels should be monitored closely in diabetic patients using this drug.


Q: What are the official guidelines for stopping Danilon treatment?

A: Official patient instructions typically advise that Danilon should be continued for the full prescribed duration, even if symptoms of the infection disappear early. Stopping the medicine too soon may allow the remaining bacteria to multiply and cause the symptoms to return.


Q: Is it a common concern that Danilon can cause fluid retention?

A: Fluid retention, or edema, is sometimes listed in official product documents as an occasional reported adverse experience. Any unusual or significant swelling should be discussed with a healthcare provider.


Q: Are there any specific blood tests required while taking Danilon?

A: While general mandatory blood tests are not always required, official documents recommend specific monitoring in certain situations. This includes close monitoring of blood glucose levels in patients with diabetes and frequent testing of Prothrombin time/INR when taken with oral anticoagulants like Warfarin.


Q: Why does Danilon sometimes require a prescription when other similar drugs do not?

A: Danilon's status as a prescription-only drug is linked to its classification as a fluoroquinolone antibiotic and its associated safety profile. Official warnings concerning the potential for serious and sometimes irreversible side effects mean that a clinical risk-benefit assessment by a healthcare provider is required before use.


Q: Are there different strengths of Danilon tablets available?

A: Official regulatory drug listings for Danilon (Norfloxacin) show that the standard tablet strength available is typically 400 mg. Dosage adjustments are made using this tablet strength in combination with frequency of administration.


Q: What is the purpose of Danilon if a person is already taking a different pain reliever?

A: The purpose of Danilon is to act as a bactericidal antibiotic to treat bacterial infections. It has no official indication as a pain reliever and serves a completely different, therapeutic function than a typical pain medication.


Q: How does Danilon impact the ability to heal from an injury?

A: Official warnings describe an increased risk of tendon rupture when taking the drug, which is a severe injury requiring significant healing. This adverse effect is a key safety caution that impacts the integrity of connective tissue.


Q: Does Danilon have a known risk of causing skin reactions or rashes?

A: Yes, official documents list a variety of skin-related adverse reactions, including a general rash, itching (pruritus), and photosensitivity (increased sun sensitivity). More rarely, severe skin reactions like Stevens-Johnson syndrome have also been reported.


Q: What research themes are commonly highlighted in academic papers about Danilon?

A: Official and associated literature focuses on several key research themes. These commonly include the investigation of bacterial resistance mechanisms, the clinical utility for various infections (particularly urinary tract infections), and the continued study of serious adverse effects like tendinopathy and Central Nervous System issues.

How should Danilon be stored and disposed of?

How to Store and Dispose of Danilon (Norfloxacin Oral Tablets)

The official labeling for Norfloxacin oral tablets mandates specific storage and disposal requirements to maintain product integrity and safety.


Storage Requirements

Category Regulatory Requirement
Temperature Store at Controlled Room Temperature (20 C to 25 C) [1].
Container Keep in the original container and maintain it tightly closed [1, 2].
Protection Must be protected from moisture [2].
Child Safety Store strictly out of the reach and sight of children [2, 3].

Disposal Instructions

Expired or unused tablets must not be flushed down the toilet, poured into drains, or placed in household trash [3, 4]. Disposal must follow local, state, and federal laws, typically requiring the medicine to be returned to a drug take-back program or an authorized collection site [3].

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Danilon found in:

A-Z Index: